Aneel Paulus

The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells

Xin Wang, Magdalena Mazurkiewicz, Ellin‐Kristina Hillert et al. · Scientific Reports · 2016 · 152 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +15

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma

Asher Chanan‐Khan, Abhisek Swaika, Aneel Paulus et al. · Blood Cancer Journal · 2013 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b‐<scp>AP</scp>15

Xin Wang, Pádraig D’Arcy, Thomas R. Caulfield et al. · Chemical Biology & Drug Design · 2015 · 96 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a <scp>SEER</scp>‐medicare analysis

Sikander Ailawadhi, Ryan D. Frank, Pooja Advani et al. · Cancer Medicine · 2017 · 88 citations · Full text

Medicine, Hematology, Oncology +13

Novel fluorinated curcuminoids and their pyrazole and isoxazole derivatives: Synthesis, structural studies, Computational/Docking and in-vitro bioassay

Kenneth K. Laali, William J. Greves, Sebastian J. Correa-Smits et al. · Journal of Fluorine Chemistry · 2017 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14